(EMAILWIRE.COM, February 05, 2019 ) Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. However, the high cost of enumeration instruments is expected to restrain market growth in the coming years.

The bioburden testing market is projected to reach $1,103 million by 2023, at a CAGR of 12.4%.

Based on application, the bioburden testing market is segmented into raw material testing, medical device testing, in-process material testing, sterilization validation testing, and equipment cleaning validation. The raw material testing segment is expected to account for the largest market share in 2018. The large share of this segment can be attributed to the rising quality standards in manufacturing to avoid consequences such as contaminations and breakdown manufacturing process.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17983056

On the basis of end users, the bioburden testing market is segmented into pharmaceutical and biotechnology companies, medical device manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories. The CMOs segment is expected to register the highest CAGR during the forecast period. The growth of the CMOs segment can be attributed to the increasing outsourcing of manufacturing processes from pharmaceutical and biotechnology companies to CMOs.

In 2018, the bioburden testing market is dominated by North America, followed by Europe, Asia, and the RoW. North America will continue to dominate the market in 2023. The large size of the North American biotechnology industry will aid the growth of the bioburden testing market in the region. However, the market in Asia is projected to witness the highest CAGR during the forecast period. Strong investments and rapid growth in the pharmaceutical and biotechnology industries will drive the growth of the bioburden testing market in this region.

Request Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=17983056